Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in DSGN — Design Therapeutics, Inc.

CIK 1000275 TORONTO, A6
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$177,314
+$56,381 QoQ
Shares Held
12,254
+7.8% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 136 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. DSGN ranks #113 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in DSGN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $177,314 12,254
2026-03-31 $120,933 11,366
2025-12-31 $5,983 638
2025-09-30 $3,350 445
2025-06-30 $12,845 3,812
2025-03-31 $10,830 2,806
2024-12-31 $25,092 4,067
2024-09-30 $26,484 4,923
2024-06-30 $9,892 2,953
2024-03-31 $2,958 734
2023-12-31 $28,617 10,799
2023-09-30 $12,982 5,501
2023-06-30 $22,515 3,574
2023-03-31 $11,920 2,066
2022-12-31 $40,206 3,919
2022-09-30 $6,921 414
2022-06-30 $2,660 190
2022-03-31 $26,389 1,634
2021-12-31 $126,339 5,901
2021-09-30 $23,356 1,590
2021-06-30 $18,338 922